Seelos Therapeutics Stock Probability of Future OTC Stock Price Finishing Under 3,833
| SEEL Stock | USD 0.39 0.11 22.00% |
Seelos |
Seelos Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Seelos Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Seelos Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Seelos Therapeutics is not yet fully synchronised with the market data | |
| Seelos Therapeutics generated a negative expected return over the last 90 days | |
| Seelos Therapeutics has high historical volatility and very poor performance | |
| Seelos Therapeutics has some characteristics of a very speculative penny stock | |
| Seelos Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 2.2 M. Net Loss for the year was (37.88 M) with loss before overhead, payroll, taxes, and interest of (46.65 M). | |
| Seelos Therapeutics currently holds about 41.25 M in cash with (23.91 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.39. |
Seelos Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Seelos OTC Stock often depends not only on the future outlook of the current and potential Seelos Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Seelos Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 4.9 M | |
| Cash And Short Term Investments | 3 M |
Seelos Therapeutics Technical Analysis
Seelos Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Seelos OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Seelos Therapeutics. In general, you should focus on analyzing Seelos OTC Stock price patterns and their correlations with different microeconomic environments and drivers.
Seelos Therapeutics Predictive Forecast Models
Seelos Therapeutics' time-series forecasting models is one of many Seelos Therapeutics' otc stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Seelos Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.
Things to note about Seelos Therapeutics
Checking the ongoing alerts about Seelos Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Seelos Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Seelos Therapeutics is not yet fully synchronised with the market data | |
| Seelos Therapeutics generated a negative expected return over the last 90 days | |
| Seelos Therapeutics has high historical volatility and very poor performance | |
| Seelos Therapeutics has some characteristics of a very speculative penny stock | |
| Seelos Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 2.2 M. Net Loss for the year was (37.88 M) with loss before overhead, payroll, taxes, and interest of (46.65 M). | |
| Seelos Therapeutics currently holds about 41.25 M in cash with (23.91 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.39. |
Other Information on Investing in Seelos OTC Stock
Seelos Therapeutics financial ratios help investors to determine whether Seelos OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Seelos with respect to the benefits of owning Seelos Therapeutics security.